|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Qu C, Liang Z, Huang J, Zhao R, Su C, Wang
S, Wang X, Zhang R, Lee MH and Yang H: MiR-205 determines the
radioresistance of human nasopharyngeal carcinoma by directly
targeting PTEN. Cell Cycle. 11:785–796. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ai MD, Li LL, Zhao XR, Wu Y, Gong JP and
Cao Y: Regulation of survivin and CDK4 by Epstein-Barr virus
encoded latent membrane protein 1 in nasopharyngeal carcinoma cell
lines. Cell Res. 15:777–784. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhen Y, Fang W, Zhao M, Luo R, Liu Y, Fu
Q, Chen Y, Cheng C, Zhang Y and Liu Z:
miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop modulated by PDCD4
suppresses cell growth, metastasis, and sensitizes nasopharyngeal
carcinoma to cisplatin. Oncogene. 36:275–285. 2017. View Article : Google Scholar
|
|
5
|
Nigg EA: Cyclin-dependent protein kinases:
Key regulators of the eukaryotic cell cycle. BioEssays. 17:471–480.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Spellman PT, Sherlock G, Zhang MQ, Iyer
VR, Anders K, Eisen MB, Brown PO, Botstein D and Futcher B:
Comprehensive identification of cell cycle-regulated genes of the
yeast Saccharomyces cerevisiae by microarray hybridization. Mol
Biol Cell. 9:3273–3297. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Champeris Tsaniras S, Kanellakis N,
Symeonidou IE, Nikolopoulou P, Lygerou Z and Taraviras S: Licensing
of DNA replication, cancer, pluripotency and differentiation: An
interlinked world? Semin Cell Dev Biol. 30:174–180. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
O'Leary B, Finn RS and Turner NC: Treating
cancer with selective CDK4/6 inhibitors. Nat Rev Clin Oncol.
13:417–430. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kumar SK, LaPlant B, Chng WJ, Zonder J,
Callander N, Fonseca R, Fruth B, Roy V, Erlichman C and Stewart AK;
Mayo Phase 2 Consortium: Dinaciclib, a novel CDK inhibitor,
demonstrates encouraging single-agent activity in patients with
relapsed multiple myeloma. Blood. 125:443–448. 2015. View Article : Google Scholar :
|
|
10
|
Ventura A and Jacks T: MicroRNAs and
cancer: Short RNAs go a long way. Cell. 136:586–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Khew-Goodall Y and Goodall GJ:
Myc-modulated miR-9 makes more metastases. Nat Cell Biol.
12:209–211. 2010.PubMed/NCBI
|
|
12
|
Ren D, Wang M, Guo W, Huang S, Wang Z,
Zhao X, Du H, Song L and Peng X: Double-negative feedback loop
between ZEB2 and miR-145 regulates epithelial-mesenchymal
transition and stem cell properties in prostate cancer cells. Cell
Tissue Res. 358:763–778. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Baranwal S and Alahari SK: miRNA control
of tumor cell invasion and metastasis. Int J Cancer. 126:1283–1290.
2010.
|
|
14
|
Ren D, Wang M, Guo W, Zhao X, Tu X, Huang
S, Zou X and Peng X: Wild-type p53 suppresses the
epithelial-mesenchymal transition and stemness in PC-3 prostate
cancer cells by modulating miR-145. Int J Oncol. 42:1473–1481.
2013.PubMed/NCBI
|
|
15
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang X, Liu J, Zang D, Wu S, Liu A, Zhu
J, Wu G, Li J and Jiang L: Upregulation of miR-572
transcriptionally suppresses SOCS1 and p21 and contributes to human
ovarian cancer progression. Oncotarget. 6:15180–15193. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang M, Ren D, Guo W, Wang Z, Huang S, Du
H, Song L and Peng X: Loss of miR-100 enhances migration, invasion,
epithelial-mesenchymal transition and stemness properties in
prostate cancer cells through targeting Argonaute 2. Int J Oncol.
45:362–372. 2014.PubMed/NCBI
|
|
18
|
Huang S, Guo W, Tang Y, Ren D, Zou X and
Peng X: miR-143 and miR-145 inhibit stem cell characteristics of
PC-3 prostate cancer cells. Oncol Rep. 28:1831–1837.
2012.PubMed/NCBI
|
|
19
|
Cai L, Ye Y, Jiang Q, Chen Y, Lyu X, Li J,
Wang S, Liu T, Cai H, Yao K, et al: Epstein-Barr virus-encoded
microRNA BART1 induces tumour metastasis by regulating
PTEN-dependent pathways in nasopharyngeal carcinoma. Nat Commun.
6:73532015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhen Y, Liu Z, Yang H, Yu X, Wu Q, Hua S,
Long X, Jiang Q, Song Y, Cheng C, et al: Tumor suppressor PDCD4
modulates miR-184-mediated direct suppression of C-MYC and BCL2
blocking cell growth and survival in nasopharyngeal carcinoma. Cell
Death Dis. 4:e8722013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Han Y, Meng F, Venter J, Wu N, Wan Y,
Standeford H, Francis H, Meininger C, Greene J Jr, Trzeciakowski
JP, et al: miR-34a-dependent overexpression of Per1 decreases
cholangio-carcinoma growth. J Hepatol. 64:1295–1304. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Aakula A, Kohonen P, Leivonen SK, Mäkelä
R, Hintsanen P, Mpindi JP, Martens-Uzunova E, Aittokallio T,
Jenster G, Perälä M, et al: Systematic identification of microRNAs
that impact on proliferation of prostate cancer cells and display
changed expression in tumor tissue. Eur Urol. 69:1120–1128. 2016.
View Article : Google Scholar
|
|
23
|
Qiu Z, Guo W, Wang Q, Chen Z, Huang S,
Zhao F, Yao M, Zhao Y and He X: MicroRNA-124 reduces the pentose
phosphate pathway and proliferation by targeting PRPS1 and RPIA
mRNAs in human colorectal cancer cells. Gastroenterology.
149:1587–1598.e11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao M, Luo R, Liu Y, Gao L, Fu Z, Fu Q,
Luo X, Chen Y, Deng X, Liang Z, et al: miR-3188 regulates
nasopharyngeal carcinoma proliferation and chemosensitivity through
a FOXO1-modulated positive feedback loop with mTOR-p-I3K/AKT-c-JUN.
Nat Commun. 7:113092016. View Article : Google Scholar
|
|
25
|
He Q, Ren X, Chen J, Li Y, Tang X, Wen X,
Yang X, Zhang J, Wang Y, Ma J, et al: miR-16 targets fibroblast
growth factor 2 to inhibit NPC cell proliferation and invasion via
PI3K/AKT and MAPK signaling pathways. Oncotarget. 7:3047–3058.
2016.
|
|
26
|
Jun GJ, Zhong GG and Ming ZS: miR-218
inhibits the proliferation of glioma U87 cells through the
inactivation of the CDK6/cyclin D1/p21(Cip1/Waf1) pathway. Oncol
Lett. 9:2743–2749. 2015.PubMed/NCBI
|
|
27
|
Schultz J, Lorenz P, Gross G, Ibrahim S
and Kunz M: MicroRNA let-7b targets important cell cycle molecules
in malignant melanoma cells and interferes with
anchorage-independent growth. Cell Res. 18:549–557. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guo W, Ren D, Chen X, Tu X, Huang S, Wang
M, Song L, Zou X and Peng X: HEF1 promotes epithelial mesenchymal
transition and bone invasion in prostate cancer under the
regulation of microRNA-145. J Cell Biochem. 114:1606–1615. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hahn WC, Dessain SK, Brooks MW, King JE,
Elenbaas B, Sabatini DM, DeCaprio JA and Weinberg RA: Enumeration
of the simian virus 40 early region elements necessary for human
cell transformation. Mol Cell Biol. 22:2111–2123. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee YM, Ting CM, Cheng YK, Fan TP, Wong
RN, Lung ML and Mak NK: Mechanisms of 2-methoxyestradiol-induced
apoptosis and G2/M cell-cycle arrest of nasopharyngeal carcinoma
cells. Cancer Lett. 268:295–307. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ghimire BR: Effects of zoledronic acid
(ZOL) on proliferation of nasopharyngeal carcinoma (NPC) cell lines
and synergistic effects of ZOL and cisplatin on NPC cell lines. J
Clin Oncol. 27:e135362009.
|
|
32
|
O'Donnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sylvestre Y, De Guire V, Querido E,
Mukhopadhyay UK, Bourdeau V, Major F, Ferbeyre G and Chartrand P:
An E2F/miR-20a autoregulatory feedback loop. J Biol Chem.
282:2135–2143. 2007. View Article : Google Scholar
|
|
34
|
Lin C, Liu A, Zhu J, Zhang X, Wu G, Ren P,
Wu J, Li M, Li J and Song L: miR-508 sustains phosphoinositide
signalling and promotes aggressive phenotype of oesophageal
squamous cell carcinoma. Nat Commun. 5:46202014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cui Y, Ma W, Lei F, Li Q, Su Y, Lin X, Lin
C, Zhang X, Ye L, Wu S, et al: Prostate tumour overexpressed-1
promotes tumourigenicity in human breast cancer via activation of
Wnt/β-catenin signalling. J Pathol. 239:297–308. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chivukula RR and Mendell JT: Circular
reasoning: microRNAs and cell-cycle control. Trends Biochem Sci.
33:474–481. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Johnson CD, Esquela-Kerscher A, Stefani G,
Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J,
Shingara J, et al: The let-7 microRNA represses cell proliferation
pathways in human cells. Cancer Res. 67:7713–7722. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Linsley PS, Schelter J, Burchard J,
Kibukawa M, Martin MM, Bartz SR, Johnson JM, Cummins JM, Raymond
CK, Dai H, et al: Transcripts targeted by the microRNA-16 family
cooperatively regulate cell cycle progression. Mol Cell Biol.
27:2240–2252. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Watanabe A, Tagawa H, Yamashita J, Teshima
K, Nara M, Iwamoto K, Kume M, Kameoka Y, Takahashi N, Nakagawa T,
et al: The role of microRNA-150 as a tumor suppressor in malignant
lymphoma. Leukemia. 25:1324–1334. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hornick NI, Doron B, Abdelhamed S, Huan J,
Harrington CA, Shen R, Cambronne XA, Chakkaramakkil Verghese S and
Kurre P: AML suppresses hematopoiesis by releasing exosomes that
contain microRNAs targeting c-MYB. Sci Signal. 9:ra882016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Leoncini PP, Bertaina A, Papaioannou D,
Flotho C, Masetti R, Bresolin S, Menna G, Santoro N, Zecca M, Basso
G, et al: MicroRNA fingerprints in juvenile myelomonocytic leukemia
(JMML) identified miR-150-5p as a tumor suppressor and potential
target for treatment. Oncotarget. 7:55395–55408. 2016.PubMed/NCBI
|
|
42
|
Sun W, Zhang Z, Wang J, Shang R, Zhou L,
Wang X, Duan J, Ruan B, Gao Y, Dai B, et al: MicroRNA-150
suppresses cell proliferation and metastasis in hepatocellular
carcinoma by inhibiting the GAB1-ERK axis. Oncotarget.
7:11595–11608. 2016.PubMed/NCBI
|
|
43
|
Ito M, Teshima K, Ikeda S, Kitadate A,
Watanabe A, Nara M, Yamashita J, Ohshima K, Sawada K and Tagawa H:
MicroRNA-150 inhibits tumor invasion and metastasis by targeting
the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma.
Blood. 123:1499–1511. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ma Y, Zhang P, Wang F, Zhang H, Yang J,
Peng J, Liu W and Qin H: miR-150 as a potential biomarker
associated with prognosis and therapeutic outcome in colorectal
cancer. Gut. 61:1447–1453. 2012. View Article : Google Scholar
|
|
45
|
Srivastava SK, Bhardwaj A, Singh S, Arora
S, Wang B, Grizzle WE and Singh AP: MicroRNA-150 directly targets
MUC4 and suppresses growth and malignant behavior of pancreatic
cancer cells. Carcinogenesis. 32:1832–1839. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wuerkenbieke D, Wang J, Li Y and Ma C:
miRNA-150 down-regulation promotes pertuzumab resistance in ovarian
cancer cells via AKT activation. Arch Gynecol Obstet.
292:1109–1116. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yin QW, Sun XF, Yang GT, Li XB, Wu MS and
Zhao J: Increased expression of microRNA-150 is associated with
poor prognosis in non-small cell lung cancer. Int J Clin Exp
Pathol. 8:842–846. 2015.PubMed/NCBI
|
|
48
|
Wu Q, Jin H, Yang Z, Luo G, Lu Y, Li K,
Ren G, Su T, Pan Y, Feng B, et al: MiR-150 promotes gastric cancer
proliferation by negatively regulating the pro-apoptotic gene EGR2.
Biochem Biophys Res Commun. 392:340–345. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Cao M, Hou D, Liang H, Gong F, Wang Y, Yan
X, Jiang X, Wang C, Zhang J, Zen K, et al: miR-150 promotes the
proliferation and migration of lung cancer cells by targeting SRC
kinase signalling inhibitor 1. Eur J Cancer. 50:1013–1024. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Papakonstantinou N, Ntoufa S,
Chartomatsidou E, Papadopoulos G, Hatzigeorgiou A, Anagnostopoulos
A, Chlichlia K, Ghia P, Muzio M, Belessi C, et al: Differential
microRNA profiles and their functional implications in different
immunogenetic subsets of chronic lymphocytic leukemia. Mol Med.
19:115–123. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang M, Cui G, Ding M, Yang W, Liu Y, Dai
D and Chen L: miR-935 promotes gastric cancer cell proliferation by
targeting SOX7. Biomed Pharmacother. 79:153–158. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhang AX, Lu FQ, Yang YP, Ren XY, Li ZF
and Zhang W: MicroRNA-217 overexpression induces drug resistance
and invasion of breast cancer cells by targeting PTEN signaling.
Cell Biol Int. 2015.Epub ahead of print. View Article : Google Scholar
|
